Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma - Bertrand, N; Guerreschi, P; Basset-Seguin, N (EClinicalMedicine, 2021)
et al.